Recently, our first full scale GMP batch for an antisense oligonucleotide was manufactured in the newly built synthesis suite at Biogen. A four-step purification process was then carried out in the existing flexible volume manufacturing facility that, up until this point, has been used for manufacturing Biogen’s protein-based parenterals.
This was our first test case to demonstrate that Biogen can manufacture ASOs safely, at scale, and achieve high purity and yield. Results are presented on the scalability of the ASO process from bench to GMP scale, highlighting successes and challenges faced with scale-up of the downstream ASO process.
Antisense Oligonucleotide Purification Process: Successes and Challenges During Scale-up is hosted by BioPharma Webinars.
Antisense Oligonucleotide Purification Process: Successes and Challenges During Scale-up is scheduled for Tuesday, September 17, 2019.
Registration or viewing is completed on BioPharma Webinars's website. UPCOMING sends visitors using referral parameters.
This is an online webinar.
The event covers Data.
EndedMay 29, 2026
BioPharma Webinars
EndedMay 5, 2026
BioPharma Webinars
EndedDec 5, 2025
BioPharma Webinars